Skip to main content
Published locations for Second-line axi-cel therapy yields high response rates in high-risk relapsed or refractory LBCL
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Second-line axi-cel therapy yields high response rates in high-risk relapsed or refractory LBCL
User login
Username
Password
Reset your password
/content/second-line-axi-cel-therapy-yields-high-response-rates-high-risk-relapsed-or-refractory-lbcl
/b-cell-lymphoma-icymi/article/266054/b-cell-lymphoma/second-line-axi-cel-therapy-yields-high